New "Virtual Liver" Technology Helps Detect Liver Tumours

Scientists and surgeons from France, Germany, United Kingdom and Switzerland have developed a "virtual liver", using EU research funding, which will help surgeons better plan and carry out tumour operations and ensure quicker patient recovery. The PASSPORT project (Patient-Specific Simulation and Pre-Operative Realistic Training) makes a uniquely accurate "virtual liver" available to physicians based on medical images sent by the radiologist to a PASSPORT online service, which helps surgeons decide whether they should or not operate. Surgeons can now see more precisely where a tumour is and where they will have to operate to safely remove it.

European Commission Vice President Neelie Kroes said: "Liver cancer claims hundreds of thousands of lives in Europe and the world. The technology developed in the EU-funded PASSPORT project is a breakthrough that will improve diagnosis and surgery, and help to save lives."

The liver performs more than 100 vital functions in the human body. Liver diseases, including cancer and sclerosis of the liver, kill thousands of people every year. Liver transplants are only an option for a very small proportion of patients with liver disease. Another option is to remove the infected part of the organ and allow the liver to regenerate. To do so, surgeons need to know the tumour’s precise location, the volume of the functional liver which would remain, and the patient's overall health in order to accurately assess the chance of a successful intervention. Under current practices, less than 50% of patients undergo surgery. PASSPORT's virtual liver could considerably increase this percentage.

The virtual software being used in the project is based on open source technology available online making it easier for surgeons to collaborate and share their analysis.

Using EU-research funding to help improve citizens' lives, medical knowledge, and enable high-tech industries are among the goals of the Digital Agenda for Europe.

First results of the project clearly demonstrate the cost effectiveness and benefits of patient-specific surgical planning. The next step is making the software commercially available. This commercialisation will be a first step towards the routine clinical use of PASSPORT results. In practice, this means that a surgeon based anywhere in the world will be able to use this model, adjust it to the needs of each patient and considerably lower the cost of each patient's operation.

The PASSPORT project started in June 2008 and ended in December 2011. The total cost was €5,457,174 of which €3,635,049 came from EU funding. PASSPORT is part of the "Virtual Physiological Human" Network of Excellence (VPH NoE). The VPH NoE is a project which aims to help support and advance European research in biomedical modelling and simulation of the human body. It allows the surgeon to zoom in from the body to the organ, from the organ to the tissue, from the tissue to the cell. It thus allows a "multi-layered" approach so specialists can track the disease and see the way in which the disease propagates through the different levels of the body.

Related article:

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...